Ahead of the game on multiple fronts. One was centralizing distribution...I am starting to hear this as the next steps companies are taking on the podcasts I listen to. Anyway, I submitted a question regarding the Bioscience Division during the Q2 Earnings call which was answered. Again, ahead of the game:
Joanne Jobin: We've got a few questions here on the bio sciences division that we announced last quarter. How is that coming along? And are there any upcoming deliverables?
Justin Dye: Yeah. We're excited about our SHWZ bio sciences business, Jim Parco is the President that business unit. He's recently hired Remy Kachadourian and a PhD in Chemistry, as Director of Innovation and Quality.
Remy is former Cannabis Lab Director and very well-known chemist in Colorado's Cannabis Industry. So we're excited to add Remy to our team. We're finalizing the construction efforts for our experimental lab, with a completion date in the third quarter.
We're also executing a development project on single source all cannabis terpenes and a move away, additives in vape products are more natural organic product line, that we think the customer will certainly appreciate and certainly asking for.
We're also actively developing partnerships with leading academic institutions, and other R&D companies to put our heads together to continue to leverage the best ideas, to continue to innovate on the product and service side. And then we have a number of other confidential things that typically you would have in your Skunk Works that we're working on that, I think we're going to have promised down the road, but more to come on that.
